Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

9.22
Delayed Data
As of Jan 18
 +0.19 / +2.10%
Today’s Change
7.20
Today|||52-Week Range
16.80
-7.06%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close9.03
Today’s open9.04
Day’s range9.02 - 9.23
Volume188,830
Average volume (3 months)631,755
Market cap$387.5M
Dividend yield--
Data as of 01/18/2017

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+16.43%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc-0.20-1.61%
NERVMinerva Neuroscience...-0.10-0.91%
MACKMerrimack Pharmaceut...-0.06-1.97%
AVDLAvadel Pharmaceutica...+0.19+1.96%
Data as of 01/18/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs